Magda Sobieszczyk

630 total citations
7 papers, 240 citations indexed

About

Magda Sobieszczyk is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Magda Sobieszczyk has authored 7 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Magda Sobieszczyk's work include HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and HIV/AIDS Research and Interventions (2 papers). Magda Sobieszczyk is often cited by papers focused on HIV Research and Treatment (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and HIV/AIDS Research and Interventions (2 papers). Magda Sobieszczyk collaborates with scholars based in United States, Peru and Thailand. Magda Sobieszczyk's co-authors include M. Cardinali, Lindsey R. Baden, Barbara Metch, John H. Eldridge, Vinai Suriyanon, John Hural, Spyros A. Kalams, Michael D. Lubeck, William A. Blattner and Artur Olhovetchi Kalichman and has published in prestigious journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Magda Sobieszczyk

7 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magda Sobieszczyk United States 5 95 84 79 68 62 7 240
Véronique Rieux France 10 93 1.0× 193 2.3× 96 1.2× 30 0.4× 64 1.0× 18 313
Sirawat Srichatrapimuk Thailand 10 41 0.4× 79 0.9× 19 0.2× 37 0.5× 137 2.2× 22 269
F. Chau France 14 209 2.2× 190 2.3× 111 1.4× 12 0.2× 54 0.9× 26 423
Laura Labate Italy 9 51 0.5× 111 1.3× 21 0.3× 16 0.2× 179 2.9× 22 304
Amudhan Murugesan India 8 96 1.0× 59 0.7× 16 0.2× 89 1.3× 57 0.9× 23 259
MarkR. Wallace United States 5 25 0.3× 37 0.4× 65 0.8× 20 0.3× 129 2.1× 5 256
Toshinori Hara Japan 10 75 0.8× 41 0.5× 16 0.2× 28 0.4× 67 1.1× 19 245
Fred Racine United States 9 164 1.7× 179 2.1× 166 2.1× 80 1.2× 254 4.1× 12 479
Graziella Hanna Pereira Brazil 9 87 0.9× 175 2.1× 53 0.7× 7 0.1× 146 2.4× 16 310
Dimitra Stafylaki Greece 9 97 1.0× 111 1.3× 59 0.7× 4 0.1× 79 1.3× 31 271

Countries citing papers authored by Magda Sobieszczyk

Since Specialization
Citations

This map shows the geographic impact of Magda Sobieszczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Sobieszczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Sobieszczyk more than expected).

Fields of papers citing papers by Magda Sobieszczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Sobieszczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Sobieszczyk. The network helps show where Magda Sobieszczyk may publish in the future.

Co-authorship network of co-authors of Magda Sobieszczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Sobieszczyk. A scholar is included among the top collaborators of Magda Sobieszczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Sobieszczyk. Magda Sobieszczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Shu, En, Magda Sobieszczyk, Patricia Segura, et al.. (2017). Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru. The International Journal of Tuberculosis and Lung Disease. 21(12). 1288–1293. 4 indexed citations
2.
Broder, Gail, James Maynard, Shelly Karuna, et al.. (2014). Implementing Good Participatory Practice (GPP) in HVTN505 - The HIV Vaccine Trials Network (HVTN) Experience. AIDS Research and Human Retroviruses. 30(S1). A105–A106. 1 indexed citations
3.
Karuna, Shelly, Doug Grove, Gail Broder, et al.. (2014). Transgender Participants in the HIV Vaccine Trial Network's HVTN 505 Trial: A Descriptive and Comparative Analysis. AIDS Research and Human Retroviruses. 30(S1). A189–A189. 1 indexed citations
4.
Kalams, Spyros A., Scott Parker, Xia Jin, et al.. (2012). Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults. PLoS ONE. 7(1). e29231–e29231. 90 indexed citations
5.
Gordon, Rachel, Haomiao Jia, Magda Sobieszczyk, et al.. (2010). The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): A Randomized Controlled Trial of Monthly Mupirocin in HIV-Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(4). 466–472. 15 indexed citations
6.
Fuchs, Jonathan D., Magda Sobieszczyk, Scott M. Hammer, & Susan Buchbinder. (2010). Lessons Drawn From Recent HIV Vaccine Efficacy Trials. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(Supplement 2). S128–S131. 11 indexed citations
7.
Sobieszczyk, Magda. (2004). Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. Journal of Antimicrobial Chemotherapy. 54(2). 566–569. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Rieux Breakdown of academic impact, for papers by Sirawat Srichatrapimuk Breakdown of academic impact, for papers by F. Chau Breakdown of academic impact, for papers by Laura Labate Breakdown of academic impact, for papers by Amudhan Murugesan Breakdown of academic impact, for papers by MarkR. Wallace Breakdown of academic impact, for papers by Toshinori Hara Breakdown of academic impact, for papers by Fred Racine Breakdown of academic impact, for papers by Graziella Hanna Pereira Breakdown of academic impact, for papers by Dimitra Stafylaki
Rankless by CCL
2026